A Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine and Influenza Combination Vaccine
Trial details
- Registry ID
- NCT06291857
- Drugs studied
- CIC Vaccine Co-formulated tNIV2 , SARSCoV-2 rS and Matrix-M Adjuvant, Fluzone High Dose, Novavax COVID-19 Vaccine, tNIV Vaccine